Clinical Study
Cancers in Togo from 1984 to 2008: Epidemiological and Pathological Aspects of 5251 Cases
Table 4
Distribution of cancers by histological nature.
| Histological group | Histological type | Nb** of cases | % |
| Carcinomas 3574 cases; 68,1% | Adenocarcinomas | 2099 | 40.0 | Squamous cell carcinoma | 1238 | 23.6 | Carcinoma NOS* | 155 | 2.9 | Urothelial carcinoma | 35 | 0.6 | Medullar carcino ma | 31 | 0.6 | Basaloid carcinoma | 19 | 0.4 | Hematopoietic tissue Cancers 833 cases; 15.9% | Non-hodgkin lymphoma | 663 | 12.6 | Hodgkin disease | 97 | 1.9 | Leukaemia | 58 | 1.1 | Myeloma | 15 | 0.3 | Sarcomas 581 cases; 11.0% | Kaposi sarcoma | 225 | 4.3 | Fibrosarcoma | 146 | 2.8 | Leiomyosarcoma | 38 | 0.7 | Rhabdomyosarcoma | 35 | 0.6 | Osteosarcoma | 30 | 0.5 | Chondrosarcoma | 28 | 0.5 | Liposarcoma | 27 | 0.5 | Angiosarcoma | 19 | 0.4 | Malignant fibrous histiocytoma | 19 | 0.4 | Ewing sarcoma | 4 | 0.1 | Sarcoma NOS* | 10 | 0.2 | Embryonic and placental malignant tumors 143 cases; 2.7% | Choriocarcinoma | 50 | 1.0 | Retinoblastoma | 38 | 0.7 | Wilms tumor | 19 | 0.4 | Malignant teratoma | 10 | 0.2 | Yolk sac tumor | 6 | 0.1 | Hepatoblastoma | 5 | 0.1 | Seminoma | 5 | 0.1 | Glioblastoma | 5 | 0.1 | Gonadoblastoma | 3 | 0.0 | Other | 2 | 0.0 | Other specified cancers 120 cases; 2.3% | Melanoma | 83 | 1.6 | Granulosa tumor | 19 | 0.4 | Mesothelioma | 7 | 0.1 | Malignant schwannoma | 8 | 0.2 | Carcinosarcoma | 3 | 0.0 |
| | All | 5251 | 100 |
|
|
*NOS: not otherwise specified. **Nb: Nomber.
|